West Pharmaceutical Services Net Change in Property, Plant, and Equipment 2010-2025 | WST

West Pharmaceutical Services annual/quarterly net change in property, plant, and equipment history and growth rate from 2010 to 2025. Net change in property, plant, and equipment can be defined as the overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sales and purchases of plant, property and equipment or is calculated as the sum of purchases and sales of PP&E
  • West Pharmaceutical Services net change in property, plant, and equipment for the quarter ending March 31, 2025 was $-0.071B, a 21.3% decline year-over-year.
  • West Pharmaceutical Services net change in property, plant, and equipment for the twelve months ending March 31, 2025 was $-0.911B, a 5.54% increase year-over-year.
  • West Pharmaceutical Services annual net change in property, plant, and equipment for 2024 was $-0.377B, a 4.14% increase from 2023.
  • West Pharmaceutical Services annual net change in property, plant, and equipment for 2023 was $-0.362B, a 27.2% increase from 2022.
  • West Pharmaceutical Services annual net change in property, plant, and equipment for 2022 was $-0.285B, a 12.31% increase from 2021.
West Pharmaceutical Services Annual Net Change in Property, Plant, and Equipment
(Millions of US $)
2024 $-377
2023 $-362
2022 $-285
2021 $-253
2020 $-174
2019 $-126
2018 $-105
2017 $-131
2016 $-170
2015 $-132
2014 $-112
2013 $-152
2012 $-131
2011 $-95
2010 $-71
2009 $-105
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $15.478B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.979B 21.73
Becton Dickinson (BDX) United States $50.635B 12.54
Cardinal Health (CAH) United States $36.940B 19.35
Straumann Holding AG (SAUHY) Switzerland $21.152B 0.00
Labcorp (LH) United States $20.992B 17.03
Cooper (COO) United States $16.298B 21.62
Align Technology (ALGN) United States $13.234B 26.27
Henry Schein (HSIC) United States $8.901B 15.27
Merit Medical Systems (MMSI) United States $5.840B 28.23
DENTSPLY SIRONA (XRAY) United States $3.330B 9.95
CONMED (CNMD) United States $1.851B 13.85
STAAR Surgical (STAA) United States $0.953B 0.00
Lifevantage (LFVN) United States $0.167B 17.21
Pro-Dex (PDEX) United States $0.145B 15.92